702 related articles for article (PubMed ID: 19381408)
1. Influence of amine ligands on the aquation and cytotoxicity of trans-diamine platinum(II) anticancer complexes.
Cubo L; Quiroga AG; Zhang J; Thomas DS; Carnero A; Navarro-Ranninger C; Berners-Price SJ
Dalton Trans; 2009 May; (18):3457-66. PubMed ID: 19381408
[TBL] [Abstract][Full Text] [Related]
2. Solution behaviour and biomolecular interactions of two cytotoxic trans-platinum(II) complexes bearing aliphatic amine ligands.
Cubo L; Casini A; Gabbiani C; Mastrobuoni G; Messori L; Jiménez-Barbero J; Navarro-Ranninger C; Quiroga AG
Chemistry; 2009 Sep; 15(36):9139-46. PubMed ID: 19655350
[TBL] [Abstract][Full Text] [Related]
3. Contrasting chemistry of cis- and trans-platinum(II) diamine anticancer compounds: hydrolysis studies of picoline complexes.
McGowan G; Parsons S; Sadler PJ
Inorg Chem; 2005 Oct; 44(21):7459-67. PubMed ID: 16212372
[TBL] [Abstract][Full Text] [Related]
4. [1H, 15N] heteronuclear single quantum coherence NMR study of the mechanism of aquation of platinum(IV) ammine complexes.
Davies MS; Hall MD; Berners-Price SJ; Hambley TW
Inorg Chem; 2008 Sep; 47(17):7673-80. PubMed ID: 18671390
[TBL] [Abstract][Full Text] [Related]
5. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
Komeda S; Kalayda GV; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
J Med Chem; 2003 Mar; 46(7):1210-9. PubMed ID: 12646031
[TBL] [Abstract][Full Text] [Related]
6. Kinetic and equilibria studies of the aquation of the trinuclear platinum phase II anticancer agent [(trans-PtCl(NH(3))(2))(2)(mu-trans-Pt(NH(3))(2)(NH(2)(CH(2))(6)NH(2))(2))](4+) (BBR3464).
Davies MS; Thomas DS; Hegmans A; Berners-Price SJ; Farrell N
Inorg Chem; 2002 Mar; 41(5):1101-9. PubMed ID: 11874344
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of aquation and anation of ruthenium(II) arene anticancer complexes, acidity and X-ray structures of aqua adducts.
Wang F; Chen H; Parsons S; Oswald ID; Davidson JE; Sadler PJ
Chemistry; 2003 Dec; 9(23):5810-20. PubMed ID: 14673852
[TBL] [Abstract][Full Text] [Related]
8. Three new asymmetric trans-amine(azole)dichloridoplatinum complexes that overcome cisplatin resistance and their reactions with 5'-GMP.
Pantoja E; Gallipoli A; van Zutphen S; Komeda S; Reddy D; Jaganyi D; Lutz M; Tooke DM; Spek AL; Navarro-Ranninger C; Reedijk J
J Inorg Biochem; 2006 Dec; 100(12):1955-64. PubMed ID: 17083978
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, X-ray crystallographic, and NMR characterizations of platinum(II) and platinum(IV) pyrophosphato complexes.
Mishur RJ; Zheng C; Gilbert TM; Bose RN
Inorg Chem; 2008 Sep; 47(18):7972-82. PubMed ID: 18693681
[TBL] [Abstract][Full Text] [Related]
10. The mechanism of action of platinum(IV) complexes in ovarian cancer cell lines.
Hall MD; Amjadi S; Zhang M; Beale PJ; Hambley TW
J Inorg Biochem; 2004 Oct; 98(10):1614-24. PubMed ID: 15458824
[TBL] [Abstract][Full Text] [Related]
11. Chloro half-sandwich osmium(II) complexes: influence of chelated N,N-ligands on hydrolysis, guanine binding, and cytotoxicity.
Peacock AF; Habtemariam A; Moggach SA; Prescimone A; Parsons S; Sadler PJ
Inorg Chem; 2007 May; 46(10):4049-59. PubMed ID: 17441712
[TBL] [Abstract][Full Text] [Related]
12. Fluorescent analogues of quinoline reveal amine ligand loss from cis and trans platinum(II) complexes in cancer cells.
New EJ; Roche C; Madawala R; Zhang JZ; Hambley TW
J Inorg Biochem; 2009 Aug; 103(8):1120-5. PubMed ID: 19564043
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, structure, and reactivity of monofunctional platinum(II) and palladium(II) complexes containing the sterically hindered ligand 6-(methylpyridin-2-yl)acetate.
Ma Y; Day CS; Bierbach U
J Inorg Biochem; 2005 Oct; 99(10):2013-23. PubMed ID: 16087242
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, characterisation and chemical reactivity of mixed-ligand platinum(II) oxadiazoline complexes with potential cytotoxic properties.
Wagner G; Marchant A; Sayer J
Dalton Trans; 2010 Sep; 39(33):7747-59. PubMed ID: 20657943
[TBL] [Abstract][Full Text] [Related]
15. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
[TBL] [Abstract][Full Text] [Related]
16. Cationic nonsymmetric transplatinum complexes with piperidinopiperidine ligands. Preparation, characterization, in vitro cytotoxicity, in vivo toxicity, and anticancer efficacy studies.
Najajreh Y; Khazanov E; Jawbry S; Ardeli-Tzaraf Y; Perez JM; Kasparkova J; Brabec V; Barenholz Y; Gibson D
J Med Chem; 2006 Jul; 49(15):4665-73. PubMed ID: 16854072
[TBL] [Abstract][Full Text] [Related]
17. Kinetic and mechanistic study of the Pt(II) versus Pt(IV) effect in the platinum-mediated nitrile-hydroxylamine coupling.
Luzyanin KV; Kukushkin VY; Ryabov AD; Haukka M; Pombeiro AJ
Inorg Chem; 2005 Apr; 44(8):2944-53. PubMed ID: 15819582
[TBL] [Abstract][Full Text] [Related]
18. Synthetic, structural and biochemical studies of polynuclear platinum(II) complexes with heterocyclic ligands.
Rubino S; Portanova P; Girasolo A; Calvaruso G; Orecchio S; Stocco GC
Eur J Med Chem; 2009 Mar; 44(3):1041-8. PubMed ID: 18676063
[TBL] [Abstract][Full Text] [Related]
19. In vitro cytotoxicity study on platinum (II) complexes with epoxysuccinates as leaving groups.
Liu X; Shen H; Zhu H; Cui K; Gou S
Bioorg Med Chem Lett; 2007 Jul; 17(14):3831-4. PubMed ID: 17533124
[TBL] [Abstract][Full Text] [Related]
20. Preparation of platinum(IV) complexes with dipeptide and diimine. X-ray crystal structure and 195Pt NMR spectra.
Watabe M; Fukuda H; Kitsukawa K; Nakajima H; Yukawa Y; Igarashi S; Fujii Y; Takayama T
J Inorg Biochem; 2006 Oct; 100(10):1653-9. PubMed ID: 16857262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
